Aral-17l is an advanced phytotherapeutic formula derived from rare wild desert plants of the Arabian Peninsula, specifically developed to support patients suffering from liver cancer, bile duct carcinoma, and gallbladder malignancies, as well as other severe hepatic and gastrointestinal conditions. This formulation is based on scientific evidence regarding the secondary bioactive metabolites of desert plants, combining a wide spectrum of antitumor, antioxidant, anti-inflammatory, and immunomodulatory effects for the natural management of liver-related pathologies.*
Aral-17l works through several integrated biological pathways:
Beyond its potent antineoplastic properties, Aral-17l demonstrates a broad pharmacological spectrum:
Aral-17l contains over 180 phenolic compounds, including:
These compounds have been scientifically documented to exert antiproliferative, hepatoprotective, neuroprotective, antioxidant, and immunomodulatory effects.